Citadel Advisors’s Nuvectra Corporation Common Stock NVTR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-17,782
Closed -$24K 10187
2019
Q3
$24K Sell
17,782
-15,906
-47% -$31.2K ﹤0.01% 8903
2019
Q2
$113K Buy
33,688
+21,777
+183% +$138K ﹤0.01% 8494
2019
Q1
$131K Sell
11,911
-18,572
-61% -$251K ﹤0.01% 8448
2018
Q4
$498K Buy
30,483
+19,101
+168% +$365K ﹤0.01% 6399
2018
Q3
$250K Sell
11,382
-2,306
-17% -$44.4K ﹤0.01% 7874
2018
Q2
$281K Buy
+13,688
New +$231K ﹤0.01% 7322

Other funds holding NVTR

Citadel Advisors's NVTR Position: Q4 2019 in Review

Citadel Advisors sold out of Nuvectra Corporation Common Stock (NVTR) in Q4 2019, closing a stake of 17,782 shares — an estimated $24K sold.

Citadel Advisors first reported a position in NVTR in Q2 2018 and held it in 6 quarters. The position peaked at $498K in Q4 2018. 7 funds tracked by Wall St. Rank hold NVTR as of Q4 2019.

  • Citadel Advisors reported no remaining Nuvectra Corporation Common Stock position as of Q4 2019 after selling out during the quarter.
  • Citadel Advisors sold 17,782 Nuvectra Corporation Common Stock shares in Q4 2019, an estimated $24K.
  • Citadel Advisors first reported a position in Nuvectra Corporation Common Stock in Q2 2018 and held it in 6 quarters.
  • Citadel Advisors's Nuvectra Corporation Common Stock position peaked at $498K in Q4 2018.
  • 7 funds tracked by Wall St. Rank held Nuvectra Corporation Common Stock as of Q4 2019.

Based on Citadel Advisors's 13F filing for Q4 2019, filed 14 Feb 2020.